Език: EN EN
← Назад към резултатите
Активно (без набиране) Фаза 3 NCT05269004

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

Фаза 3 – широко изпитване преди одобрение
Заболявания: Multiple Sclerosis

Спонсор: Hoffmann-La Roche

Налично на: БГ
Обобщение
This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche sponsored Parent study who continue to receive ocrelizumab or are in safety follow-up at the time of the closure of their respective Parent study (WA21092, WA21093 or WA25046) are eligible for enrollment in this extension study. Participants who will continue ocrelizumab treatment will receive IMP based on the dosage and administration received at the time of rollover from the Parent study.
Кой може да участва
Inclusion criteria * Prior eligibility for and previous participation in 1 of the Roche-sponsored Parent Studies WA21092, WA21093, or WA25046 with the participant either receiving ocrelizumab as an investigational medicinal product (IMP) or being in safety follow-up after treatment discontinuation * For female participants of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use adequate acceptable contraception during the treatment period and for at least 6 months or longer if the local label is more stringent after the final dose of ocrelizumab, as applicable in the ocrelizumab package leaflet Exclusion criteria * Concurrent participation in any clinical trial (other than the Parent study) * Unable or unwilling to comply with the requirements of the protocol
Места на провеждане 32
Argentina (1)
Hospital Español
Ciudad Autonoma Bs As
Австралия (1)
Royal North Shore Hospital
St Leonards , New South Wales
Belarus (1)
Grodno University Hospital
Grodno , Brest Oblast
Бразилия (1)
HC-UFG - Hospital das Clínicas da Universidade Federal de Goiás
Goinia , Goiás
България (1)
MHAT Avis Medica OOD Department of Neurology
Pleven
Канада (1)
Calgary MS Clinic
Calgary , Alberta
Хърватия (1)
General Hospital Varazdin
Varaždin
Чехия (1)
Fakultni nemocnice Brno
Brno
Estonia (1)
West Tallinn Central Hospital
Tallinn
Финландия (1)
Tammer Tutka Oy
Tampere
Франция (1)
CHU CAEN - Hôpital de la Côte de Nacre
Caen , Calvados
Германия (1)
Universitaetsklinikum Tuebingen
Tübingen , Baden-Wurttemberg
Унгария (1)
S-Medicon Egeszsegugyi Szolgaltato Kft.
Budapest
Израел (1)
Hadassah University Hospital - Ein Kerem
Jerusalem
Италия (1)
Azienda Socio Sanitaria Territoriale della Valle Olona (pres
Gallarate , Aosta Valley
Latvia (1)
Maritime Medicine Centre of Latvia Hospital of Vecmilgravis Department of Neurology
Riga
Lithuania (1)
Hospital of Lithuanian University of Health Sciences Kaunas Clinics Public Institution
Kaunas
Mexico (1)
Hospital Mexico Americano
Guadalajara , Mexico CITY (federal District)
Нидерландия (1)
Zuyderland Medisch Centrum - Sittard-Geleen'
Sittard-Geleen
New Zealand (1)
Waikato Hospital
Hamilton
Норвегия (1)
Haukeland Universitetssykehus
Bergen
Полша (1)
NZOZ Vitamed
Bydgoszcz
Румъния (1)
Spitalul Universitar de Urgenta Elias
Bucharest
Russia (1)
Siberian Medical Center
Barnaul , Altayskiy Kray
Сърбия (1)
Clinical Center Kragujevac
Kragujevac
Словакия (1)
MUDr. Beata Dupejova Neurologicka ambulancia s.r.o
Banská Bystrica
Испания (1)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat , Barcelona
Швеция (1)
Sahlgrenska Sjukhuset
Gothenburg
Tunisia (1)
Hopital Razi
Mannouba
Ukraine (1)
Medical Center of Limited Liability Company Medical Center Saliutem
Vinnytsia , Chernihiv Governorate
Великобритания (1)
Nottingham University Hospitals Queen's Medical Centre
Nottingham , Nottinghamshire
САЩ (1)
Barrow Neurological Institute
Phoenix , Arizona
Технически детайли
Статус
Активно (без набиране)
Фаза
Фаза 3
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Здрави доброволци
Не
Начална дата
03.05.2022
Крайна дата
31.12.2027
Регистрационен номер
NCT05269004
Източник
anzctr
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.